Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 4.84% and Operating profit at -10.98% over the last 5 years
2
The company has declared Negative results for the last 10 consecutive quarters
3
With ROE of 5.11%, it has a fair valuation with a 1.64 Price to Book Value
4
Market Beating Performance
Stock DNA
Chemicals & Petrochemicals
CNY 11,734 Million (Large Cap)
32.00
NA
0.79%
0.08
5.11%
1.64
Revenue and Profits:
Net Sales:
996 Million
(Quarterly Results - Jun 2025)
Net Profit:
162 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.11%
0%
8.11%
6 Months
26.15%
0%
26.15%
1 Year
12.64%
0%
12.64%
2 Years
-13.32%
0%
-13.32%
3 Years
-16.73%
0%
-16.73%
4 Years
-43.27%
0%
-43.27%
5 Years
-30.05%
0%
-30.05%
Valiant Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.84%
EBIT Growth (5y)
-10.98%
EBIT to Interest (avg)
30.09
Debt to EBITDA (avg)
0.22
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.48
Tax Ratio
5.91%
Dividend Payout Ratio
37.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.08%
ROE (avg)
10.52%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.64
EV to EBIT
37.90
EV to EBITDA
15.92
EV to Capital Employed
1.59
EV to Sales
3.46
PEG Ratio
NA
Dividend Yield
0.79%
ROCE (Latest)
4.20%
ROE (Latest)
5.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
996.20
846.90
17.63%
Operating Profit (PBDIT) excl Other Income
256.50
223.60
14.71%
Interest
5.80
5.70
1.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
161.60
108.50
48.94%
Operating Profit Margin (Excl OI)
146.60%
133.70%
1.29%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 17.63% vs -7.86% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 48.94% vs 1,195.96% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,642.90
4,256.90
-14.42%
Operating Profit (PBDIT) excl Other Income
854.00
1,322.60
-35.43%
Interest
32.30
35.30
-8.50%
Exceptional Items
-39.30
26.80
-246.64%
Consolidate Net Profit
383.20
881.70
-56.54%
Operating Profit Margin (Excl OI)
108.90%
203.10%
-9.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -14.42% vs -15.79% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -56.54% vs 6.98% in Dec 2023
About Valiant Co., Ltd. 
Valiant Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






